Purpose: To validate a vascular severity score as an appropriate output for artificial intelligence (AI) Software as a Medical Device (SaMD) for retinopathy of prematurity (ROP) through comparison with ordinal disease severity labels for stage and plus disease assigned by the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), committee. Design: Validation study of an AI-based ROP vascular severity score. Participants: A total of 34 ROP experts from the ICROP3 committee. Methods: Two separate datasets of 30 fundus photographs each for stage (0–5) and plus disease (plus, preplus, neither) were labeled by members of the ICROP3 committee using an open-source platform. Averaging these results produced a continuous label for plus (1–9) and stage (1–3) for each image. Experts were also asked to compare each image to each other in terms of relative severity for plus disease. Each image was also labeled with a vascular severity score from the Imaging and Informatics in ROP deep learning system, which was compared with each grader's diagnostic labels for correlation, as well as the ophthalmoscopic diagnosis of stage. Main Outcome Measures: Weighted kappa and Pearson correlation coefficients (CCs) were calculated between each pair of grader classification labels for stage and plus disease. The Elo algorithm was also used to convert pairwise comparisons for each expert into an ordered set of images from least to most severe. Results: The mean weighted kappa and CC for all interobserver pairs for plus disease image comparison were 0.67 and 0.88, respectively. The vascular severity score was found to be highly correlated with both the average plus disease classification (CC = 0.90, P < 0.001) and the ophthalmoscopic diagnosis of stage (P < 0.001 by analysis of variance) among all experts. Conclusions: The ROP vascular severity score correlates well with the International Classification of Retinopathy of Prematurity committee member's labels for plus disease and stage, which had significant intergrader variability. Generation of a consensus for a validated scoring system for ROP SaMD can facilitate global innovation and regulatory authorization of these technologies.

Campbell, J. P., Chiang, M. F., Chen, J. S., Moshfeghi, D. M., Nudleman, E., Ruambivoonsuk, P., Cherwek, H., Cheung, C. Y., Singh, P., Kalpathy-Cramer, J., Ostmo, S., Eydelman, M., Chan, R. V. P., Capone, A., Lepore, D., Collaborative Community In Ophthalmic Imaging Executive Committee And The Collaborative Community In Ophthalmic Imaging Retinopathy Of Prematurity, W., Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis, <<OPHTHALMOLOGY>>, 2022; 129 (7): N/A-N/A. [doi:10.1016/j.ophtha.2022.02.008] [https://hdl.handle.net/10807/302901]

Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis

Lepore, Domenico;
2022

Abstract

Purpose: To validate a vascular severity score as an appropriate output for artificial intelligence (AI) Software as a Medical Device (SaMD) for retinopathy of prematurity (ROP) through comparison with ordinal disease severity labels for stage and plus disease assigned by the International Classification of Retinopathy of Prematurity, Third Edition (ICROP3), committee. Design: Validation study of an AI-based ROP vascular severity score. Participants: A total of 34 ROP experts from the ICROP3 committee. Methods: Two separate datasets of 30 fundus photographs each for stage (0–5) and plus disease (plus, preplus, neither) were labeled by members of the ICROP3 committee using an open-source platform. Averaging these results produced a continuous label for plus (1–9) and stage (1–3) for each image. Experts were also asked to compare each image to each other in terms of relative severity for plus disease. Each image was also labeled with a vascular severity score from the Imaging and Informatics in ROP deep learning system, which was compared with each grader's diagnostic labels for correlation, as well as the ophthalmoscopic diagnosis of stage. Main Outcome Measures: Weighted kappa and Pearson correlation coefficients (CCs) were calculated between each pair of grader classification labels for stage and plus disease. The Elo algorithm was also used to convert pairwise comparisons for each expert into an ordered set of images from least to most severe. Results: The mean weighted kappa and CC for all interobserver pairs for plus disease image comparison were 0.67 and 0.88, respectively. The vascular severity score was found to be highly correlated with both the average plus disease classification (CC = 0.90, P < 0.001) and the ophthalmoscopic diagnosis of stage (P < 0.001 by analysis of variance) among all experts. Conclusions: The ROP vascular severity score correlates well with the International Classification of Retinopathy of Prematurity committee member's labels for plus disease and stage, which had significant intergrader variability. Generation of a consensus for a validated scoring system for ROP SaMD can facilitate global innovation and regulatory authorization of these technologies.
2022
Inglese
Campbell, J. P., Chiang, M. F., Chen, J. S., Moshfeghi, D. M., Nudleman, E., Ruambivoonsuk, P., Cherwek, H., Cheung, C. Y., Singh, P., Kalpathy-Cramer, J., Ostmo, S., Eydelman, M., Chan, R. V. P., Capone, A., Lepore, D., Collaborative Community In Ophthalmic Imaging Executive Committee And The Collaborative Community In Ophthalmic Imaging Retinopathy Of Prematurity, W., Artificial Intelligence for Retinopathy of Prematurity: Validation of a Vascular Severity Scale against International Expert Diagnosis, <<OPHTHALMOLOGY>>, 2022; 129 (7): N/A-N/A. [doi:10.1016/j.ophtha.2022.02.008] [https://hdl.handle.net/10807/302901]
File in questo prodotto:
File Dimensione Formato  
artificial.pdf

accesso aperto

Tipologia file ?: Versione Editoriale (PDF)
Licenza: Creative commons
Dimensione 1.09 MB
Formato Adobe PDF
1.09 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/302901
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 39
  • ???jsp.display-item.citation.isi??? 33
social impact